Report: Combination therapy more effective for diabetics

03/25/2008 | Reuters

A report shows that a combination of simvastatin and fenofibrate works better than either drug alone at normalizing lipid levels in Type 2 diabetes patients who do not have coronary heart disease. "Aggressive treatment of this mixed dyslipidemia may be very important in saving the lives of our diabetic patients," a researcher said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ
RN Care Manager
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC